Takeda - Top 10 Layoffs of 2010

Company: Takeda
Layoffs: 1,400

Scoop: As Takeda prepares for diabetes drug Actos' patent expiration, it announced 1,400 jobs cut within the U.S. "The business environment for the pharmaceutical industry is changing dramatically," the company says in a statement, "with the pharmaceutical industry as a whole facing barriers to technological innovation that have halted progress in breakthrough novel drugs, stricter approval processes for new drugs in advanced nations, and radical upheaval in healthcare systems."

The cuts came primarily from Takeda's U.S. headquarters in Deerfield, IL and the Takeda Global Research and Development Center.

Takeda - Top 10 Layoffs of 2010
Read more on

Suggested Articles

While the failure might be a missed chance at revenue, it shouldn’t hurt Ibrance’s ability to rack up sales in the metastatic setting, one exec says.

Patients receiving Bavencio actually did worse than those who got placebo, increasing the risk of death by 31%.

Seattle Genetics and Astellas’ newcomer Padcev now has what every cancer drugmaker is looking for: Randomized trial data showing it can extend lives.